ORIC
Closed
Oric Pharmaceuticals inc
10.14
-0.01 (-0.10%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 10.15
Day's Range: 9.8 - 10.33
Send
sign up or login to leave a comment!
When Written:
5.79
Oric Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on developing therapies for cancer treatment. The company is based in Durham, North Carolina, and was founded in 2014. Oric Pharmaceuticals aims to develop novel treatments for cancer patients by targeting specific cancer cell signaling pathways. The company's lead product candidate, ORIC-101, is a small molecule inhibitor of the glucocorticoid receptor that is being evaluated in clinical trials for the treatment of solid tumors. Oric Pharmaceuticals has also developed a pipeline of other product candidates that target other cancer cell signaling pathways. The company has partnerships with several academic institutions and pharmaceutical companies to advance its research and development efforts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








